Author | Lori J. Goldstein, MD | OncLive

Author | Lori J. Goldstein, MD

Articles

Dr. Lori Goldstein on Neoadjuvant Treatment for HER2+ Breast Cancer

February 04, 2015

Video

Lori Goldstein, MD, the director of the Naomi and Phil Lippincott Breast Evaluation Center, Fox Chase Cancer Center, discusses a neoadjuvant trial of lapatinib and trastuzumab with or without endocrine therapy for 12 weeks vs. 24 weeks in patients with HER2 overexpressing breast cancer.

Dr. Goldstein on Mechanisms of Resistance to Endocrine Therapy

July 19, 2014

Video

Lori Goldstein, MD, director, The Naomi and Phil Lippincott Breast Evaluation Center, deputy associate director, Clinical Research, Fox Chase Cancer Center, discusses mechanisms of resistance to endocrine therapy.

Dr. Goldstein on the Fox Chase Breast Evaluation Center

October 28, 2011

Video

Dr. Lori Goldstein from Fox Chase Cancer Center on the Fox Chase Breast Evaluation Center

Dr. Goldstein on Fulvestrant in Metastatic Breast Cancer

October 26, 2011

Video

Dr. Lori Goldstein from Fox Chase Cancer Center on Fulvestrant in Metastatic Breast Cancer

x